Clinical verification of the performance of the pathwork tissue of origin test: Utility and limitations

American Journal of Clinical Pathology

Volumn 136, Issue 6, 2011, Pages 924-933

  Dumur, Catherine I ^a   Fuller, Christine E ^a   Blevins, Tana L ^a   Schaum, Julia C ^a   Wilkinson, David S ^a   Garrett, Carleton T ^a   Powers, Celeste N ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Cancer of unknown primary site; Metastasis; Microarray; Tissue of origin; Undifferentiated tumor

Indexed keywords

CARBOPLATIN; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 7; ESTROGEN RECEPTOR; MELAN A; PACLITAXEL; RNA; TRANSCRIPTION FACTOR CDX2;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER OF UNKNOWN PRIMARY SITE; CANCER TISSUE; CLINICAL ARTICLE; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CANCER; LUNG TUMOR; MALE; OVARY CANCER; PANCREAS CANCER; PATHWORK TISSUE OF ORIGIN TEST; PRIORITY JOURNAL; SALIVARY GLAND CANCER; TISSUE MICROARRAY; TUMOR BIOPSY; TUMOR DIFFERENTIATION;

BRAIN NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASMS; NEOPLASMS, UNKNOWN PRIMARY;

EID: 82655171619     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPDQPFO73SSNFR     Document Type: Article

References (31)

1. Abbruzzese JL, Abbruzzese MC, Lenzi R, et al. Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin. J Clin Oncol. 1995;13:2094-2103.
2. Pavlidis N, Fizazi K. Cancer of unknown primary (CUP). Crit Rev Oncol Hematol. 2005;54:243-250. (Pubitemid 40693686)
3. Chu PG, Weiss LM. Keratin expression in human tissues and neoplasms. Histopathology. 2002;40:403-439. (Pubitemid 34535443)
4. Park SY, Kim BH, Kim JH, et al. Panels of immunohistochemical markers help determine primary sites of metastatic adenocarcinoma. Arch Pathol Lab Med. 2007;131:1561-1567.
5. Su AI, Welsh JB, Sapinoso LM, et al. Molecular classification of human carcinomas by use of gene expression signatures. Cancer Res. 2001;61:7388-7393. (Pubitemid 32995021)
6. Bloom G, Yang IV, Boulware D, et al. Multi-platform, multisite, microarray-based human tumor classification. Am J Pathol. 2004;164:9-16. (Pubitemid 38364584)
7. Ramaswamy S, Tamayo P, Rifkin R, et al. Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci U S A. 2001;98:15149-15154. (Pubitemid 34013984)
8. Tothill RW, Kowalczyk A, Rischin D, et al. An expressionbased site of origin diagnostic method designed for clinical application to cancer of unknown origin. Cancer Res. 2005;65:4031-4040. (Pubitemid 40775639)
9. Ma XJ, Patel R, Wang X, et al. Molecular classification of human cancers using a 92-gene real-time quantitative polymerase chain reaction assay. Arch Pathol Lab Med. 2006;130:465-473.
10. Talantov D, Baden J, Jatkoe T, et al. A quantitative reverse transcriptase-polymerase chain reaction assay to identify metastatic carcinoma tissue of origin. J Mol Diagn. 2006;8:320-329. (Pubitemid 44063808)
11. Varadhachary GR, Raber MN, Matamoros A, et al. Carcinoma of unknown primary with a colon-cancer profilechanging paradigm and emerging definitions. Lancet Oncol. 2008;9:596-599. (Pubitemid 351722584)
12. Monzon FA, Lyons-Weiler M, Buturovic LJ, et al. Multicenter validation of a 1,550-gene expression profile for identification of tumor tissue of origin. J Clin Oncol. 2009;27:2503-2508.
13. Pillai R, Deeter R, Rigl CT, et al. Validation and reproducibility of a microarray-based gene expression test for tumor identification in formalin-fixed, paraffin-embedded specimens. J Mol Diagn. 2011;13:48-56.
14. Horlings HM, van Laar RK, Kerst JM, et al. Gene expression profiling to identify the histogenetic origin of metastatic adenocarcinomas of unknown primary. J Clin Oncol. 2008;26:4435-4441.
15. Bridgewater J, van Laar R, Floore A, et al. Gene expression profiling may improve diagnosis in patients with carcinoma of unknown primary. Br J Cancer. 2008;98:1425-1430.
16. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6:857-866. (Pubitemid 44629897)
17. Rosenfeld N, Aharonov R, Meiri E, et al. MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol. 2008;26:462-469. (Pubitemid 351501813)
18. Dumur CI, Lyons-Weiler M, Sciulli C, et al. Interlaboratory performance of a microarray-based gene expression test to determine tissue of origin in poorly differentiated and undifferentiated cancers. J Mol Diagn. 2008;10:67-77. (Pubitemid 351184837)
19. Clinical and Laboratory Standards Institute. Verification and validation of multiplex nucleic-acid assays; Approved guideline. Wayne, PA: Clinical and Laboratory Standards Institute; 2008. Document MM17-A.
20. Dumur CI, Sana S, Ladd AC, et al. Assessing the impact of tissue devitalization time on genome-wide gene expression analysis in ovarian tumor samples. Diagn Mol Pathol. 2008;17:200-206.
21. Dumur CI, Nasim S, Best AM, et al. Evaluation of qualitycontrol criteria for microarray gene expression analysis. Clin Chem. 2004;50:1994-2002. (Pubitemid 39425835)
22. Wilson EB. Probable inference, the law of succession, and statistical inference. J Am Stat Assoc. 1927;22:209-212.
23. Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med. 1998;17:857-872. (Pubitemid 28185165)
24. Gomez-Fernandez C, Mejias A, Walker G, et al. Immunohistochemical expression of estrogen receptor in adenocarcinomas of the lung: the antibody factor. Appl Immunohistochem Mol Morphol. 2010;18:137-141.
25. Wu AH, Drees JC, Wang H, et al. Gene expression profiles help identify the tissue of origin for metastatic brain cancers. Diagn Pathol. 2010;5:26. doi:10.1186/1746-1596-5-26.
26. Monzon FA, Medeiros F, Lyons-Weiler M, et al. Identification of tissue of origin in carcinoma of unknown primary with a microarray-based gene expression test. Diagn Pathol. 2010;5:3. doi:10.1186/1746-1596-5-3.
27. Pomjanski N, Grote HJ, Doganay P, et al. Immunocytochemical identification of carcinomas of unknown primary in serous effusions. Diagn Cytopathol. 2005;33:309-315. (Pubitemid 41598050)
28. Dennis JL, Hvidsten TR, Wit EC, et al. Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm. Clin Cancer Res. 2005;11:3766-3772. (Pubitemid 40685594)
29. Schapira DV, Jarrett AR. The need to consider survival, outcome, and expense when evaluating and treating patients with unknown primary carcinoma. Arch Intern Med. 1995;155:2050-2054.
30. Varadhachary GR, Talantov D, Raber MN, et al. Molecular profiling of carcinoma of unknown primary and correlation with clinical evaluation. J Clin Oncol. 2008;26:4442-4448.
31. Lau SK, Prakash S, Geller SA, et al. Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma. Hum Pathol. 2002;33:1175-1181. (Pubitemid 36020066)